[克隆性血液形成及其骨髓增殖性瘤的演变]
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin 300020, China.
Zhonghua yi xue za zhi
|November 29, 2023
概括
骨髓增殖性瘤 (MPN) 涉及驱动和非驱动基因突变. 了解这些突变的克隆进化是管理MPN并发症,疾病转变和患者生存的关键.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 骨髓增殖性瘤 (MPN) 的特点是特定的基因突变.
- 克隆性血液形成,即MPN相关突变的存在,可以在MPN诊断之前几十年.
- 基因突变,炎症和治疗之间的相互作用影响着MPN的进展.
研究的目的:
- 审查MPN中的基因突变.
- 分析克隆进化的对血栓形成,白血病和纤维化转变的影响.
- 为了确定影响MPN的克隆进化因素.
主要方法:
- 对MPN遗传学和克隆进化现有文献的综述.
- 对驱动和非驱动突变的分析,包括JAK2,CALR,MPL,ASXL1,TET2等.
- 讨论突变的时间顺序及其对疾病表型的影响.
主要成果:
- 驱动突变 (JAK2,CALR,MPL) 和非驱动突变有助于MPN的发展.
- 克隆性血液形成及其演变显著影响MPN并发症,如血栓形成和转化为白血病或纤维化.
- 诸如炎症和干扰素治疗等因素调节了克隆性血液形成和疾病的过程.
结论:
- 了解MPN的克隆造血和演变对于预测并发症和预后至关重要.
- 需要进一步的研究,以解决有关MPN克隆进化的当前知识的局限性.
- 本综述总结了克隆造血和进化对MPN结果的影响.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


